Evidence map›Paper›PMID 36143775›Full record

ReviewMaterials (Basel, Switzerland)2022

A Brief Review: The Use of L-Ascorbic Acid as a Green Reducing Agent of Graphene Oxide.

Mariano Palomba, Gianfranco Carotenuto, Angela Longo

Abstract readReview
In one paragraph

Review in Materials (Basel, Switzerland), 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 11 papers.

0numbers the graph read from it
0cells of the map it votes in
11citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

11 citing papers in PubMed.

  1. Review
  2. Article
  3. Review
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors.

Mariano PalombaInstitute for Polymers, Composites, and Biomaterials, National Research Council, SS Napoli/Portici, Piazzale Enrico Fermi 1, 80055 Portici, Italy.
Gianfranco CarotenutoInstitute for Polymers, Composites, and Biomaterials, National Research Council, SS Napoli/Portici, Piazzale Enrico Fermi 1, 80055 Portici, Italy.ORCID 0000-0001-6609-8168
Angela LongoInstitute for Polymers, Composites, and Biomaterials, National Research Council, SS Napoli/Portici, Piazzale Enrico Fermi 1, 80055 Portici, Italy.ORCID 0000-0002-4952-0600

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The reduced form of graphene oxide (r-GO) represents a versatile precursor to obtain graphene derivatives. Graphene oxide (GO) consists of a layered material based on a carbon skeleton functionalized by different oxygen-containing groups, while r-GO is obtained by the almost complete removal of these oxygen-containing functional groups. The r-GO has mechanical, electrical, and optical properties quite similar to graphene, thus, it proves to be a convenient 2D material useful for many technological applications. Nowadays, the most important aspects to consider in producing r-GO are: (i) the possibility of obtaining the highest reduction grade; (ii) the possibility of improving the dispersion stability of the resulting graphene using surfactants; (iii) the use of environmentally friendly and inexpensive reducing agents. Consequently, the availability of effective soft-chemistry approaches based on a green reducing agent for converting GO to r-GO are strongly needed. Among the green reductants, the most suitable is L-ascorbic acid (L-aa). Different studies have revealed that L-aa can achieve C/O ratio and conductivity values comparable to those obtained by hydrazine, a typical reducing agent. These aspects could promote an effective application strategy, and for this reason, this review summarizes and analyzes, in some detail, the up-to date literature on the reduction of GO by L-aa. The results are organized according to the two most important approaches, which are the reduction in liquid-phase, and the reduction in gel-phase. Reaction mechanisms and different experimental parameters affecting the processes were also compared.

Indexed as

gel-phase reductiongraphene oxideL-ascorbic acidliquid-phase reductionreduced graphene oxide

Identifiers

PMID36143775
PMCPMC9505528

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.